GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Scaled Net Operating Assets: N/A (As of Mar. 2026)

GlaxoSmithKline Pharmaceuticals Scaled Net Operating Assets Related Terms

The historical data trend for GlaxoSmithKline Pharmaceuticals's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GlaxoSmithKline Pharmaceuticals Scaled Net Operating Assets Chart

GlaxoSmithKline Pharmaceuticals Annual Data
	Trend	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24	Mar25	Mar26
Scaled Net Operating Assets		Get a 7-Day Free Trial					-0.07	0.02	-0.02	-0.15	-0.11

GlaxoSmithKline Pharmaceuticals Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

NSE:GLAXO vs LLY, JNJ, ABBV: Scaled Net Operating Assets Comparison

For the Drug Manufacturers - General subindustry, GlaxoSmithKline Pharmaceuticals's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GlaxoSmithKline Pharmaceuticals Scaled Net Operating Assets vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Pharmaceuticals's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline Pharmaceuticals's Scaled Net Operating Assets falls into.

GlaxoSmithKline Pharmaceuticals Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

GlaxoSmithKline Pharmaceuticals's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2026 is calculated as

where

GlaxoSmithKline Pharmaceuticals's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2026 is calculated as

where

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GlaxoSmithKline Pharmaceuticals Business Description